Enrichment of target sequences for nextgeneration sequencing applications in research and diagnostics

Biological Chemistry

Volumn 395, Issue 2, 2014, Pages 231-237

  Altmüller, Janine ^a   Budde, Birgit S ^a   Nürnberg, Peter ^a,b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Gene panel sequencing; Target enrichment

Indexed keywords

BASE SEQUENCE; BIOMEDICAL RESEARCH; HUMANS; PATHOLOGY, MOLECULAR; SEQUENCE ANALYSIS, DNA;

EID: 84893720512     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2013-0199     Document Type: Review

References (31)

1. Bakker, E. (2006). Is the DNA sequence the gold standard in genetic testing? Quality of molecular genetic tests assessed. Clin. Chem. 52, 557-558.
2. Becker, K., Vollbrecht, C., Koitzsch, U., Koenig, K., Fassunke, J., Huss, S., Nuernberg, P., Heukamp, L.C., Buettner, R., Odenthal, M., et al. (2013). Deep ion sequencing of amplicon adapter ligated libraries: a novel tool in molecular diagnostics of formalin fixed and paraffin embedded tissues. J. Clin. Pathol. 66, 803-806.
3. Charlesworth, G., Plagnol, V., Holmstrom, K.M., Bras, J., Sheerin, U.M., Preza, E., Rubio-Agusti, I., Ryten, M., Schneider, S.A., Stamelou, M., et al. (2012). Mutations in ANO3 cause dominant craniocervical dystonia: ion channel implicated in pathogenesis. Am. J. Hum. Genet. 91, 1041-1050.
4. Costa, J.L., Sousa, S., Justino, A., Kay, T., Fernandes, S., Cirnes, L., Schmitt, F., and Machado, J.C. (2013). Nonoptical massive parallel DNA sequencing of BRCA1 and BRCA2 genes in a diagnostic setting. Hum. Mutat. 34, 629-635.
5. Dames, S., Chou, L.S., Xiao, Y., Wayman, T., Stocks, J., Singleton, M., Eilbeck, K., and Mao, R. (2013). The development of next-generation sequencing assays for the mitochondrial genome and 108 nuclear genes associated with mitochondrial disorders. J. Mol. Diagn. 15, 526-534.
6. Duncavage, E.J., Abel, H.J., Szankasi, P., Kelley, T.W., and Pfeifer, J.D. (2012). Targeted next generation sequencing of clinically significant gene mutations and translocations in leukemia. Modern Pathol. 25, 795-804.
7. Feng, B.J., Tavtigian, S.V., Southey, M.C., and Goldgar, D.E. (2011). Design considerations for massively parallel sequencing studies of complex human disease. PLoS One 6, e23221.
8. Forshew, T., Murtaza, M., Parkinson, C., Gale, D., Tsui, D.W., Kaper, F., Dawson, S.J., Piskorz, A.M., Jimenez-Linan, M., Bentley, D., et al. (2012). Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci. Transl. Med. 4, 136ra68.
9. Gargis, A.S., Kalman, L., Berry, M.W., Bick, D.P., Dimmock, D.P., Hambuch, T., Lu, F., Lyon, E., Voelkerding, K.V., Zehnbauer, B.A., et al. (2012). Assuring the quality of next-generation sequencing in clinical laboratory practice. Nat. Biotechnol. 30, 1033-1036.
10. Hiatt, J.B., Pritchard, C.C., Salipante, S.J., O'Roak, B.J., and Shendure, J. (2013). Single molecule molecular inversion probes for targeted, high-accuracy detection of low-frequency variation. Genome Res. 23, 843-854.
11. Hollants, S., Redeker, E.J., and Matthijs, G. (2012). Microfluidic amplification as a tool for massive parallel sequencing of the familial hypercholesterolemia genes. Clin. Chem. 58, 717-724.
12. Hubers, A.J., Heideman, D.A., Yatabe, Y., Wood, M.D., Tull, J., Taron, M., Molina, M.A., Mayo, C., Bertran-Alamillo, J., Herder, G.J., et al. (2013). EGFR mutation analysis in sputum of lung cancer patients: a multitechnique study. Lung Cancer. DOI: 10.1016/j.lungcan.2013.07.011. [Epub ahead of print].
13. Huebner, A.K., Gandia, M., Frommolt, P., Maak, A., Wicklein, E.M., Thiele, H., Altmuller, J., Wagner, F., Vinuela, A., Aguirre, L.A., et al. (2011). Nonsense mutations in SMPX, encoding a protein responsive to physical force, result in X-chromosomal hearing loss. Am. J. Hum. Genet. 88, 621-627.
14. Johansson, H., Isaksson, M., Sorqvist, E.F., Roos, F., Stenberg, J., Sjoblom, T., Botling, J., Micke, P., Edlund, K., Fredriksson, S., et al. (2011). Targeted resequencing of candidate genes using selector probes. Nucleic Acids Res. 39, e8.
15. Kalender, A.Z., De, K.K., Gianfelici, V., Geerdens, E., Vandepoel, R., Pauwels, D., Porcu, M., Lahortiga, I., Brys, V., Dirks, W.G., et al. (2012). High accuracy mutation detection in leukemia on a selected panel of cancer genes. PLoS One 7, e38463.
16. Katsanis, S.H. and Katsanis, N. (2013). Molecular genetic testing and the future of clinical genomics. Nat. Rev. Genet. 14, 415-426.
17. Kerick, M., Isau, M., Timmermann, B., Sultmann, H., Herwig, R., Krobitsch, S., Schaefer, G., Verdorfer, I., Bartsch, G., Klocker, H., et al. (2011). Targeted high throughput sequencing in clinical cancer settings: formaldehyde fixed-paraffin embedded (FFPE) tumor tissues, input amount and tumor heterogeneity. Med. Genomics 4, 68.
18. Ku, C.S., Cooper, D.N., Iacopetta, B., and Roukos, D.H. (2013). Integrating next-generation sequencing into the diagnostic testing of inherited cancer predisposition. Clin. Genet. 83, 2-6.
19. Lal, D., Becker, K., Motameny, S., Altmuller, J., Thiele, H., Nurnberg, P., Ahting, U., Rolinski, B., Neubauer, B.A., and Hahn, A. (2013). Homozygous missense mutation of NDUFV1 as the cause of infantile bilateral striatal necrosis. Neurogenetics 14, 85-87.
20. Lee, J.E., Choi, J.H., Lee, J.H., and Lee, M.G. (2005). Gene SNPs and mutations in clinical genetic testing: haplotype-based testing and analysis. Mutat. Res. 573, 195-204.
21. Lopes, L.R., Zekavati, A., Syrris, P., Hubank, M., Giambartolomei, C., Dalageorgou, C., Jenkins, S., McKenna, W., Plagnol, V., and Elliott, P.M. (2013). Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing. J. Med. Genet. 50, 228-239.
22. Mertes, F., Elsharawy, A., Sauer, S., van Helvoort, J.M., van der Zaag, P.J., Franke, A., Nilsson, M., Lehrach, H., and Brookes, A.J. (2011). Targeted enrichment of genomic DNA regions for next-generation sequencing. Brief. Funct. Genomics 10, 374-386.
23. Querings, S., Altmuller, J., Ansen, S., Zander, T., Seidel, D., Gabler, F., Peifer, M., Markert, E., Stemshorn, K., Timmermann, B., et al. (2011). Benchmarking of mutation diagnostics in clinical lung cancer specimens. PLoS One 6, e19601.
24. Sarhadi, V.K., Lahti, L., Scheinin, I., Tyybakinoja, A., Savola, S., Usvasalo, A., Raty, R., Elonen, E., Ellonen, P., Saarinen-Pihkala, U.M., et al. (2013). Targeted resequencing of 9p in acute lymphoblastic leukemia yields concordant results with array CGH and reveals novel genomic alterations. Genomics 102, 182-188.
25. Schrauwen, I., Sommen, M., Corneveaux, J.J., Reiman, R.A., Hackett, N.J., Claes, C., Claes, K., Bitner-Glindzicz, M., Coucke, P., Van, C.G., et al. (2013). A sensitive and specific diagnostic test for hearing loss using a microdroplet PCR-based approach and next generation sequencing. Am. J. Med. Genet. A 161A, 145-152.
26. Schweiger, M.R., Kerick, M., Timmermann, B., Albrecht, M.W., Borodina, T., Parkhomchuk, D., Zatloukal, K., and Lehrach, H. (2009). Genome-wide massively parallel sequencing of formaldehyde fixed-paraffin embedded (FFPE) tumor tissues for copy-number- and mutation-analysis. PLoS One 4, e5548.
27. Shendure, J. and Lieberman, A.E. (2012). The expanding scope of DNA sequencing. Nat. Biotechnol. 30, 1084-1094.
28. Singh, R.R., Patel, K.P., Routbort, M.J., Reddy, N.G., Barkoh, B.A., Handal, B., Kanagal-Shamanna, R., Greaves, W.O., Medeiros, L.J., Aldape, K.D., et al. (2013). Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes. J. Mol. Diagn. 15, 607-622.
29. Wagle, N., Berger, M.F., Davis, M.J., Blumenstiel, B., Defelice, M., Pochanard, P., Ducar, M., Van, H.P., Macconaill, L.E., Hahn, W.C., et al. (2012). High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing. Cancer Discov. 2, 82-93.
30. Walsh, T., Lee, M.K., Casadei, S., Thornton, A.M., Stray, S.M., Pennil, C., Nord, A.S., Mandell, J.B., Swisher, E.M., and King, M.C. (2010). Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing. Proc. Natl. Acad. Sci. USA 107, 12629-12633.
31. Wieczorek, D., Bogershausen, N., Beleggia, F., Steiner-Haldenstatt, S., Pohl, E., Li, Y., Milz, E., Martin, M., Thiele, H., Altmuller, J., et al. (2013). A comprehensive molecular study on Coffin-Siris and Nicolaides-Baraitser syndromes identifies a broad molecular and clinical spectrum converging on altered chromatin remodeling. Hum. Mol. Genet. DOI: 10.1093/hmg/ddt366. [Epub ahead of print].